Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data
暂无分享,去创建一个
Sean S. Park | A. Degnim | J. Boughey | B. Stish | T. Hieken | K. Ruddy | Haeyoung Kim | K. Furutani | A. Conners | J. Jakub | C. Deufel | K. Corbin | R. Mutter | D. Shumway | F. Abraha | Safia K. Ahmed | Nicole P. Sandhu | M. Piltin
[1] F. Vicini,et al. Partial breast irradiation: An updated consensus statement from the American brachytherapy society. , 2022, Brachytherapy.
[2] A. Amini,et al. An Examination of Nationwide Trends in Accelerated Partial Breast Irradiation - The Replacement of Breast Brachytherapy with Intraoperative Radiotherapy and External Beam Radiation. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] F. Vicini,et al. Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice. , 2021, JCO oncology practice.
[4] B. Hickey,et al. Partial breast irradiation versus whole breast radiotherapy for early breast cancer. , 2021, The Cochrane database of systematic reviews.
[5] R. Schiappa,et al. APBI versus ultra APBI in the elderly with low-risk breast cancer: a comparative analysis of oncological outcome and late toxicity. , 2021, International journal of radiation oncology, biology, physics.
[6] Ning Zhang,et al. Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer , 2021, JCO oncology practice.
[7] Yi Zhou,et al. The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis , 2020, Frontiers in Oncology.
[8] M. Duma,et al. DEGRO practical guideline for partial-breast irradiation , 2020, Strahlentherapie und Onkologie.
[9] B. Bunnell,et al. Obesity-Altered Adipose Stem Cells Promote Radiation Resistance of Estrogen Receptor Positive Breast Cancer through Paracrine Signaling , 2020, International journal of molecular sciences.
[10] F. Vicini,et al. Modern Approaches for Breast Brachytherapy. , 2020, Seminars in radiation oncology.
[11] W. Curran,et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial , 2019, The Lancet.
[12] R. Schiappa,et al. Accelerated partial breast irradiation in the elderly: 5-Year results of the single fraction elderly breast irradiation (SiFEBI) phase I/II trial. , 2019, Brachytherapy.
[13] F. Vicini,et al. Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial. , 2019, International journal of radiation oncology, biology, physics.
[14] Sean S. Park,et al. Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen. , 2019, International journal of radiation oncology, biology, physics.
[15] M. Ferri,et al. Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results , 2018, Journal of contemporary brachytherapy.
[16] Sean S. Park,et al. Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience , 2018, Breast Cancer Research and Treatment.
[17] F. Vicini,et al. Six-Year Results From a Phase I/II Trial for Hypofractionated Accelerated Partial Breast Irradiation Using a 2-Day Dose Schedule , 2017, American journal of clinical oncology.
[18] Alphonse G. Taghian,et al. Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. , 2017, Practical radiation oncology.
[19] R. Pötter,et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial , 2017, The Lancet. Oncology.
[20] P. Goodwin,et al. Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] C. Yashar,et al. Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study. , 2016, Brachytherapy.
[22] Sean S. Park,et al. Feasibility and full-course dosimetry of an intraoperatively placed multichannel brachytherapy catheter for accelerated partial breast irradiation. , 2016, Brachytherapy.
[23] A. Szabo,et al. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer. , 2016, International journal of radiation oncology, biology, physics.
[24] A. Olshan,et al. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study , 2016, Breast Cancer Research.
[25] F. Vicini,et al. Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer. , 2016, International journal of radiation oncology, biology, physics.
[26] P. Catalano,et al. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer , 2016, Annals of Surgical Oncology.
[27] Sean S. Park,et al. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer , 2016, Annals of Surgical Oncology.
[28] G. De Pergola,et al. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications. , 2016, The oncologist.
[29] K. Czene,et al. Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] N. Mukhopadhyay,et al. Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial. , 2014, International journal of radiation oncology, biology, physics.
[31] F. Vicini,et al. Treatment Efficacy with Accelerated Partial Breast Irradiation (APBI): Final Analysis of the American Society of Breast Surgeons MammoSite® Breast Brachytherapy Registry Trial , 2013, Annals of Surgical Oncology.
[32] Early Breast Cancer Trialists' Collaborative Group. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.
[33] Dawn L Hershman,et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] R. Pötter,et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[35] T. Pawlicki,et al. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] P. Čičovački. SOCIETY , 2008, Society.
[37] Marcel Garcia,et al. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. , 2004, Critical reviews in oncology/hematology.
[38] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.